A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

461

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Benign Prostatic Hyperplasia (BPH)
Interventions
DRUG

Silodosin

8 mg daily for 12 weeks

OTHER

Placebo

1 capsule daily for 12 weeks

Trial Locations (43)

Unknown

Huntsville

Tucson

Anaheim

Culver City

Irvine

La Jolla

Long Beach

Newport Beach

San Diego

Aurora

Wheat Ridge

Waterbury

Aventura

Clearwater

Coral Gables

Pensacola

Marietta

Chicago

Peoria

Des Moines

Saint Joseph

Edina

Missoula

Las Vegas

Bay Shore

Garden City

Manhasset

New York

Staten Island

Williamsville

Charlotte

Salisbury

Winston-Salem

Cincinnati

Bethany

Portland

Lancaster

Greer

Dallas

Salt Lake City

Lakewood

Tacoma

Milwaukee

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00224107 - A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo | Biotech Hunter | Biotech Hunter